Back to Journals » Vascular Health and Risk Management » Volume 2 » Issue 1

ESCI
SJR OA
CiteScore
Impact Factor

Vascular Health and Risk Management

ISSN: 1178-2048


       

Archive: Volume 2, 2006


Evaluation of efficacy and safety of fixed dose lovastatin and niacinER combination in Asian Indian dyslipidemic patients: a multicentric study

Manoj Sharma, Deepika R Sharma, Vikram Singh, RB Panwar, HS Hira, Bishav Mohan, Naveen Kumar, SK Sharma, Rajeev Gupta

Vascular Health and Risk Management 2006, 2:87-93

Published Date: 15 March 2006

Effects of eprosartan on target organ protection

Alejandro de la Sierra

Vascular Health and Risk Management 2006, 2:79-85

Published Date: 15 March 2006

Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes

Catherine A Schnabel, Matthew Wintle, Orville Kolterman

Vascular Health and Risk Management 2006, 2:69-77

Published Date: 15 March 2006

Insulin glargine in the treatment of type 1 and type 2 diabetes 59

Anthony H Barnett

Vascular Health and Risk Management 2006, 2:59-67

Published Date: 15 March 2006

Ximelagatran: direct thrombin inhibitor

Shir-Jing Ho, Tim A Brighton

Vascular Health and Risk Management 2006, 2:49-58

Published Date: 15 March 2006

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel or both?

Matthew A Silva, Jennifer L Donovan, Pritesh J Gandhi, Gregory A Volturo

Vascular Health and Risk Management 2006, 2:39-48

Published Date: 15 March 2006

Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination

Ryan C Neal, Peter H Jones

Vascular Health and Risk Management 2006, 2:31-38

Published Date: 15 March 2006

Noninvasive assessment of preclinical atherosclerosis

Helen A Lane, Jamie C Smith, J Stephen Davies

Vascular Health and Risk Management 2006, 2:19-30

Published Date: 15 March 2006

Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa

Todd W Rice

Vascular Health and Risk Management 2006, 2:3-18

Published Date: 15 March 2006

Editorial: Incidence of stroke after myocardial infarction ||FREE PAPER||

Reza Tabrizchi

Vascular Health and Risk Management 2006, 2:1-2

Published Date: 15 March 2006